Parabilis Medicines, Inc.
PBLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001657677
No open-market purchases or sales by Parabilis Medicines, Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $2.71B in total; no superinvestor holds it.
SEC filings
10-K, 10-Q, 8-K, 20-F and 40-F reports Parabilis Medicines, Inc. filed with the SEC, newest first.
Livermore lists each filing's form, 8-K items and dates only. To read a filing, open it on SEC.gov; an 8-K's press release or other attachments, such as exhibit 99.1 for Item 2.02, are in the filing index.
| Filed | Form | 8-K items | Period | Document | Filing index |
|---|---|---|---|---|---|
| Nov 5, 2026 | 8-K | 1.01 | Oct 30, 2026 | SEC | Index |
| Sep 15, 2026 | 8-K | 7.01 | Sep 15, 2026 | SEC | Index |
| Sep 2, 2026 | 8-K | 5.02 | Aug 28, 2026 | SEC | Index |
| Aug 25, 2026 | 8-K | 5.027.019.01 | Aug 22, 2026 | SEC | Index |
| Aug 13, 2026 | 10-Q | – | Jun 30, 2026 | SEC | Index |
| Aug 13, 2026 | 8-K | 2.027.019.01 | Aug 13, 2026 | SEC | Index |
| Jun 11, 2026 | 8-K | 1.013.025.039.01 | Jun 9, 2026 | SEC | Index |